120 related articles for article (PubMed ID: 18186272)
1. [The tactic of targeting the parietal pleura for controlling malignant pleural effusion].
Ohta Y
Kyobu Geka; 2008 Jan; 61(1):43-6. PubMed ID: 18186272
[TBL] [Abstract][Full Text] [Related]
2. Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
Ohta Y; Shimizu Y; Matsumoto I; Watanabe G
J Exp Clin Cancer Res; 2006 Mar; 25(1):15-9. PubMed ID: 16761613
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review of lung cancer patients with pleural dissemination after limited operations combined with parietal pleurectomy.
Ohta Y; Shimizu Y; Matsumoto I; Tamura M; Oda M; Watanabe G
J Surg Oncol; 2005 Sep; 91(4):237-42. PubMed ID: 16121347
[TBL] [Abstract][Full Text] [Related]
4. Multimodality treatment including parietal pleurectomy as a possible therapeutic procedure for malignant pleural effusion.
Ohta Y; Oda M; Shimizu J; Watanabe G
Surg Technol Int; 2007; 16():184-9. PubMed ID: 17429787
[TBL] [Abstract][Full Text] [Related]
5. [Limited pleuro-pneumonectomy for bronchogenic carcinoma associated with cancerous pleural effusion].
Liu J; Zhang G; Jiang G; Peng J; Shen C; Li M
Zhonghua Wai Ke Za Zhi; 1999 Oct; 37(10):633-4. PubMed ID: 11829912
[TBL] [Abstract][Full Text] [Related]
6. [Two patients of recurrent breast cancer with carcinomatous pleurisy well controlled pleural effusion].
Hojo S; Maeura Y; Fukunaga H; Yoshioka S; Ota H; Endo W; Yamazaki K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1795-7. PubMed ID: 16315944
[TBL] [Abstract][Full Text] [Related]
7. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of malignant pleural effusions by parietal pleurectomy].
Ortlieb H; Schildge J; Cegla M
Helv Chir Acta; 1987 Nov; 54(3):325-8. PubMed ID: 3436824
[No Abstract] [Full Text] [Related]
9. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
[TBL] [Abstract][Full Text] [Related]
10. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy.
Ishikawa Y; Matsuguma H; Nakahara R; Suzuki H; Ui A; Kondo T; Kamiyama Y; Igarashi S; Mori K; Kodama T; Yokoi K
Ann Thorac Surg; 2009 Sep; 88(3):952-7. PubMed ID: 19699926
[TBL] [Abstract][Full Text] [Related]
11. [Using a pleural implantable access system for the management of malignant pleural effusions. Experience of Institut Curie].
Daniel C; Kriegel I; Di Maria S; Patrubani G; Livartowski A; Estève M
Rev Pneumol Clin; 2008 Feb; 64(1):8-14. PubMed ID: 18603173
[TBL] [Abstract][Full Text] [Related]
12. Recurrent pleural effusion: who benefits from a tunneled pleural catheter?
Schneider T; Reimer P; Storz K; Klopp M; Pfannschmidt J; Dienemann H; Hoffmann H
Thorac Cardiovasc Surg; 2009 Feb; 57(1):42-6. PubMed ID: 19169996
[TBL] [Abstract][Full Text] [Related]
13. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
Yildirim H; Metintas M; Ak G; Metintas S; Erginel S
Lung Cancer; 2008 Oct; 62(1):139-44. PubMed ID: 18403045
[TBL] [Abstract][Full Text] [Related]
14. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
Aydogmus U; Ozdemir S; Cansever L; Sonmezoglu Y; Kocaturk CI; Bedirhan MA
Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
[TBL] [Abstract][Full Text] [Related]
15. [Thoracentesis and pleurodesis in the treatment of pleural effusion. Personal experience].
Pisello F; Geraci G; Sciumè C; Li Volsi F; Platia L; Facella T; Romeo M; Modica G
G Chir; 2008; 29(6-7):299-304. PubMed ID: 18544270
[TBL] [Abstract][Full Text] [Related]
16. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Richards WG; Sugarbaker DJ
Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
[TBL] [Abstract][Full Text] [Related]
17. Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis.
Sioris T; Sihvo E; Salo J; Räsänen J; Knuuttila A
Eur J Surg Oncol; 2009 May; 35(5):546-51. PubMed ID: 18644696
[TBL] [Abstract][Full Text] [Related]
18. Parietal pleurectomy for malignant pleural effusion.
Fry WA; Khandekar JD
Ann Surg Oncol; 1995 Mar; 2(2):160-4. PubMed ID: 7728570
[TBL] [Abstract][Full Text] [Related]
19. Early experience with videothoracoscopic hydrodissection pleurectomy in the treatment of malignant pleural effusion.
Harvey JC; Erdman CB; Beattie EJ
J Surg Oncol; 1995 Aug; 59(4):243-5. PubMed ID: 7630172
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
